Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Otsuka Pharmaceutical Co. v. Zydus Pharmaceuticals USA, No. 16-1962 (Fed. Cir. July 20, 2017)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1962
Also Docketed
No. 16-1963, No. 16-1964, No. 16-1966, No. 16-1968, No. 16-1970, No. 16-1971, No. 16-1972, No. 16-1973, No. 16-1974, No. 16-1975, No. 16-1978 (consolidated; same document)
Decided
July 20, 2017
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
4 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

OTSUKA PHARMACEUTICAL CO., LTD.,

Plaintiff-Appellant

v.

ZYDUS PHARMACEUTICALS USA, INC., CADILA HEALTHCARE, LIMITED, MYLAN INC., MYLAN

PHARMACEUTICALS INC., TORRENT

PHARMACEUTICALS LIMITED, TORRENT

PHARMA INC., HETERO LABS LIMITED, AJANTA PHARMA LIMITED, AJANTA PHARMA USA INC.,

AUROBINDO PHARMA LTD., INTAS

PHARMACEUTICALS LIMITED, ACCORD

HEALTHCARE, INC., AUROBINDO PHARMA USA INC., AUROLIFE PHARMA LLC, LUPIN LIMITED,

LUPIN ATLANTIS HOLDINGS S.A., LUPIN

PHARMACEUTICALS, INC., ALEMBIC

PHARMACEUTICALS LIMITED, AMNEAL

PHARMACEUTICALS, LLC, AMNEAL

PHARMACEUTICALS INDIA PVT. LTD.,

Defendants-Appellees

2016-1962, 2016-1963, 2016-1964, 2016-1966, 2016-1968, 2016-1970, 2016-1971, 2016-1972, 2016-1973, 2016-1974,

2016-1975, 2016-1978

Appeals from the United States District Court for the District of New Jersey in Nos. 1:14-cv-03168-JBS-KMW,

21:14-cv-04508-JBS-KMW, 1:14-cv-04671-JBS-KMW, 1:14-cv-05876-JBS-KMW, 1:14-cv-06158-JBS-KMW, 1:14-cv-06890-JBS-KMW, 1:14-cv-07105-JBS-KMW, 1:14-cv-07252-JBS-KMW, 1:14-cv-07405-JBS-KMW, 1:14-cv-08074-JBS-KMW, 1:14-cv-08077-JBS-KMW, 1:15-cv-01585-JBS-KMW, Chief Judge Jerome B. Simandle.

JUDGMENT

PAUL WILLIAM BROWNING, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for plaintiff-appellant. Also represented by JAMES B. MONROE, CHARLES THOMAS COLLINS-CHASE, ERIC JAY FUES, ANDREA DENISE MAIN; JEFFREY ANDREW FREEMAN, Atlanta, GA. LAWRENCE M. SUNG, Wiley Rein, LLP, Washington, DC, argued for all defendants-appellees. Defendant-appellees Torrent Pharmaceuticals Limited, Torrent Pharma Inc. also represented by ADITYA NEAL SETH, RACHEL KAPUST HUNNICUTT.

CHAD A. LANDMON, Axinn Veltrop Harkrider, LLP, Hartford, CT, for defendants-appellees Zydus Pharmaceuticals USA, Inc., Cadila Heathcare, Limited. Also represented by DELPHINE W. KNIGHT BROWN, New York, NY. DEEPRO MUKERJEE, Alston & Bird LLP, New York, NY, for defendants-appellees Mylan Inc., Mylan Pharmaceuticals Inc. Also represented by LANCE SODERSTROM; TRAVIS JAMES IAMS, Charlotte, NC. MARGARET E. IVES, Choate, Hall & Stewart LLP, Boston, MA, for defendant-appellee Hetero Labs Limited. Also represented by PHOEBE FISCHER-GROBAN.

3SAILESH K. PATEL, Schiff Hardin LLP, Chicago, IL, for defendant-appellees Ajanta Pharma Limited, Ajanta Pharma USA Inc. Also represented by HELEN H. JI. BRIAN WM. HIGGINS, Blank Rome LLP, Washington, DC, for defendants-appellees Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Aurolife Pharma LLC. Also represented by GERARD HADDAD, CHRISTOPHER K. HU, New York, NY. PAUL BRAIER, Greenblum & Bernstein, P.L.C., Reston, VA, for defendants-appellees Intas Pharmaceuticals Limited, Accord Healthcare, Inc. Also represented by PETER BRANKO PEJIC.

DOUGLASS C. HOCHSTETLER, Kelley Drye & Warren, LLP, Chicago, IL, for defendants-appellees Lupin Limited, Lupin Atlantis Holdings S.A., Lupin Pharmaceuticals, Inc. Also represented by CLIFFORD KATZ, New York, NY. DENNIES VARUGHESE, Sterne Kessler Goldstein & Fox, PLLC, Washington, DC, for defendant-appellee Alembic Pharmaceuticals Limited. Also represented by CHANDRIKA VIRA, JON WRIGHT.

RONALD MARC DAIGNAULT, Polsinelli PC, New York, NY, for defendants-appellees Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals India Pvt. Ltd. Also represented by KAREN ZELLE MORRIS, St. Louis, MO.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Circuit Judges).

4AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

July 20, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Otsuka Pharmaceutical Co. v. Zydus Pharmaceuticals USA, No. 16-1962 (Fed. Cir. July 20, 2017).

govinfo ID
USCOURTS-ca13-16-01962-0
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-16-01962-0

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.